A Patient-Reported Outcome Measure of Communication Difficulties in Friedreich Ataxia: COMATAX.
Open Access
- 23 May 2026
- journal article
- Published by Springer Nature in The Cerebellum
- Vol. 25 (4)
Abstract
Background and Objectives: Friedreich ataxia (FA) causes progressive impairment of communication due to gradual deterioration of speech, associated with impaired hearing, socio-cognitive and language skills. There is an urgent need to investigate the impact of this multiparametric alteration on patients’ lives. Therefore, the COMunication and ATAXia measure (COMATAX) was developed and validated in French and German. Methods: In the PROFA study (NCT05943002), we conducted focus groups and cognitive interviews with patients with FA, professionals and caregivers to elaborate relevant items of communication disabilities. Subsequently, the measure was validated in 93 patients with FA via a mobile health app. For validation, distribution properties, reliability (Cronbach’s alpha) and validity (correlations with VHI-30, SSQ-12, SARA total score, SARA speech item, Speech rate and GAA repeats; known-groups validity by age, sex, and self-rated health/wellbeing, disease-severity, hearing function, daily activities, and exploratory factor analysis) were calculated. An IRT analysis was performed to assess item characteristics. Results: COMATAX consists of 17 items (five response options each) and an 18th question asking about the most bothersome symptom. We observed high internal consistency for the total COMATAX scale (α = 0.897), strong correlations with VHI-30 ( r =.894), SSQ-12 ( r = −.531), moderate with SARA score ( r =.498), SARA speech item ( r =.416), Speech rate ( r =-.354), weak with GAA repeat length (r GAA1 =-0.207) and the ability to distinguish between different subgroups (disease severity, self-rated health, wellbeing, hearing function, and daily activities). Most items showed good discrimination of communication ability. Conclusion: The COMATAX is a valid and reliable patient-reported communication disability measure, useful in future therapeutic trials in FA.Keywords
Funding Information
- Canadian Institutes of Health Research–Institute of Genetics
- Bundesministerium für Ernährung und Landwirtschaft (01GM2110)
- EJP RD (825575)
- Agence Nationale de la Recherche (ANR21-RAR4-0003-04);)
This publication has 39 references indexed in Scilit:
- The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022Applied Health Economics and Health Policy, 2023
- Development and Validation of a Patient‐Reported Outcome Measure of AtaxiaMovement Disorders, 2021
- Rapid exhaustion of auditory neural conduction in a prototypical mitochondrial disease, Friedreich ataxiaClinical Neurophysiology, 2018
- Personality and Neuropsychological Profiles in Friedreich AtaxiaThe Cerebellum, 2017
- Different Measures, Different Outcomes? A Systematic Review of Performance-Based versus Self-Reported Measures of Health Literacy and NumeracyJournal of General Internal Medicine, 2015
- Friedreich's ataxia impact scale: A new measure striving to provide the flexibility required by today's studiesMovement Disorders, 2009
- Friedreich ataxia: The clinical pictureJournal of Neurology, 2009
- Speech Handicap Index in patients with oral and pharyngeal cancer: Better understanding of patients' complaintsHead & Neck, 2008
- Validierung des Voice Handicap Index (VHI) in der deutschen FassungHNO, 2003
- Coefficient Alpha and the Internal Structure of TestsPsychometrika, 1951